CA3130884A1 — Antimicrobial skin cream
Assigned to Individual · Expires 2021-01-07 · 5y expired
What this patent protects
This invention relates to compounds that treat microbial skin infections. Previously, powered forms of talk were difficult to apply to skin without becoming a lung irritant. Embodiments of the present invention use talc, lanolin, petroleum jelly, sodium lauryl ether sulfate, sodi…
USPTO Abstract
This invention relates to compounds that treat microbial skin infections. Previously, powered forms of talk were difficult to apply to skin without becoming a lung irritant. Embodiments of the present invention use talc, lanolin, petroleum jelly, sodium lauryl ether sulfate, sodium chloride, water, sodium salicylate, Lauryl ether sulfate, Isopropyl palmitate, propylene glycol, mineral oil, and sodium benzoate.
Drugs covered by this patent
- Xiidra (LIFITEGRAST) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.